Taiho Oncology, Inc.
Taiho Oncology is seeking a Director for Regulatory CMC to manage global regulatory activities outside Asia, providing strategic guidance for drug development, approval, and post-approval processes. The role involves leading the preparation of regulatory submissions, interacting with authorities, and ensuring compliance with global standards. This position offers a global experience working closely with a multidisciplinary team dedicated to advancing cancer treatments.
Headquarters
Princeton, New Jersey, United States
Company Size
201-500 employees
Founded
2002
Taiho Oncology, Inc. is a U.S.-based biopharmaceutical company focused on discovering, developing, and commercializing innovative cancer treatments. The company works across oncology research, clinical development, and patient support to bring therapies to people living with cancer. Taiho Oncology operates in the biotechnology and pharmaceutical industry as part of the broader Taiho Pharmaceutical Group.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Taiho Oncology, Inc..
53% above the average for this role
Senior Director CMC Regulatory Affairs
Immunovant, Inc.
Senior Director, Regulatory Affairs CMC
Mirum Pharmaceuticals
Global Regulatory Affairs (CMC) Manager
Integrated Resources INC
Director, Global CMC Regulatory
Revolution Medicines
Director, CMC Regulatory Affairs
Regeneron Pharmaceuticals
CMC Regulatory Affairs Manager
Integrated Resources INC